Cresco Labs announced the closing of a $50 million revolving credit facility with Needham Bank, providing the cannabis operator with additional financial flexibility to support growth initiatives, acquisitions, and general corporate purposes.
The financing marks a notable development for both Cresco Labs and the broader cannabis industry, where operators have historically relied on private credit markets with higher borrowing costs due to limited access to traditional banking services. The new facility reflects increasing access to conventional commercial bank financing for established cannabis companies.
The revolving credit facility carries a fixed annual interest rate of 7.99% and matures in August 2030. As a non-dilutive source of capital, the facility is expected to support Cresco Labs’ strategy of pursuing acquisitions and growth opportunities while strengthening its balance sheet and long-term financial profile.
The company said the additional capital flexibility aligns with its disciplined growth and consolidation strategy. Cresco Labs recently completed an acquisition in Pennsylvania and believes further opportunities exist to deploy capital into assets that can enhance earnings, improve margins, and create long-term shareholder value.
Needham Bank will also provide Cresco Labs with a broader suite of financial services, including credit, cash management, and consumer payment solutions. The Massachusetts-based commercial bank highlighted its ability to deliver a compliant nationwide banking platform tailored to the needs of one of the largest publicly traded multistate cannabis operators in the United States.
The agreement comes as cannabis operators continue seeking greater access to mainstream financial services and capital markets. Cresco Labs said the facility positions the company to support future growth while working toward broader access to U.S. capital markets and a potential uplisting to a senior exchange.
KEY QUOTES:
“This facility reflects both the continued maturation of the industry and Cresco’s position within it. Access to conventional bank capital gives us a powerful, non-dilutive tool to accelerate our strategy. As demonstrated by our recent Pennsylvania acquisition, we see significant opportunities to deploy capital into assets that enhance earnings, improve margins and create long-term shareholder value. This added flexibility positions us to drive growth, strengthen our balance sheet and support Cresco as we work toward broader access to U.S. capital markets and a future uplisting to a senior exchange.”
Charlie Bachtell, Chief Executive Officer, Cresco Labs
“In addition to providing financing to fuel Cresco Labs’ growth, Needham Bank is also providing a comprehensive suite of financial services including credit, state-of-the-art cash management and consumer payments to Cresco Labs, one of the largest publicly traded, multistate cannabis companies in the U.S. Our ability to provide a compliant, nationwide banking platform perfectly aligns with their strong operational and financial profile. We look forward to building a rewarding relationship with Cresco Labs for many years to come.”
Michelle Haughton, First Vice President, Structured Finance, Needham Bank
